Letter: Levamisole.
作者信息
Webster D J, Hughes L E
出版信息
Lancet. 1975 Apr 19;1(7912):917-8. doi: 10.1016/s0140-6736(75)91715-8.
PMID:47559
Abstract
摘要
相似文献
1
Letter: Levamisole.信件：左旋咪唑。
Lancet. 1975 Apr 19;1(7912):917-8. doi: 10.1016/s0140-6736(75)91715-8.
2
Letter: Levamisole and the immune response.信函：左旋咪唑与免疫反应。
N Engl J Med. 1973 Nov 22;289(21):1148-9. doi: 10.1056/NEJM197311222892121.
3
Levamisole and the new era of chemoimmunotherapy.
Cancer Invest. 1991;9(1):111-24. doi: 10.3109/07357909109032808.
4
Letter: Levamisole.信件：左旋咪唑。
Lancet. 1975 Feb 15;1(7903):389.
5
Letter: Levamisole and bone-marrow restoration after chemotherapy.信函：左旋咪唑与化疗后的骨髓恢复
Lancet. 1976 Mar 6;1(7958):548. doi: 10.1016/s0140-6736(76)90351-2.
6
Levamisole: known effects on the immune system, clinical results, and future applications to the treatment of cancer.左旋咪唑：对免疫系统的已知影响、临床结果以及在癌症治疗中的未来应用。
J Clin Oncol. 1991 Nov;9(11):2052-66. doi: 10.1200/JCO.1991.9.11.2052.
7
Letter: Levamisole.信件：左旋咪唑。
Lancet. 1975 Apr 12;1(7911):867. doi: 10.1016/s0140-6736(75)93057-3.
8
Letter: Levamisole.
Lancet. 1975 Mar 8;1(7906):574-5.
9
Clinical experiences with levamisole.
Adv Exp Med Biol. 1976;73 PT-A:424-7.
10
Letter: diogenes syndrome.信件：第欧根尼综合征。
Lancet. 1975 Mar 29;1(7909):750-1. doi: 10.1016/s0140-6736(75)91665-7.
引用本文的文献
1
Enhancement of delayed cutaneous hypersensitivity in untreated cancer patients given a short-term oral treatment with C 1821.给予未治疗的癌症患者短期口服C 1821后，其迟发型皮肤超敏反应增强。
Cancer Immunol Immunother. 1982;14(1):59-60. doi: 10.1007/BF00199434.
2
Restoration by levamisole of immune responses suppressed in tumor-bearing mice.左旋咪唑对荷瘤小鼠中被抑制的免疫反应的恢复作用。
Cancer Immunol Immunother. 1983;15(2):121-5. doi: 10.1007/BF00199702.
Zotero 插件